Form 4 for CVS CVS Health
Accepted 2024-04-03 00:00:00 ET · period of report 2024-04-01 · accession 0001127602-24-012258 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-04-03 | 2024-04-01 | CVS | Shah Prem S | EVP, Pres-Pharm, Consumer W | F - Tax | $79.56 | -7,892 | 47.3K | -14% | -$627.9K |
| D | 2024-04-03 | 2024-04-01 | CVS | Shah Prem S | EVP, Pres-Pharm, Consumer W | A - Grant | $0.00 | +15.1K | 37.1K | +69% | $0 |
| D | 2024-04-03 | 2024-04-01 | CVS | Shah Prem S | EVP, Pres-Pharm, Consumer W | A - Grant | $79.56 | +62.7K | 62.7K | New | +$4.99M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-04-01 | F | D | 5,239 | $79.56 | 42,034.46 | D | — | — | |
| 2 | Common | Common Stock (Restricted) | 2024-04-01 | A | A | 15,082 | $0.00 | 37,057 | D | — | — | |
| 3 | Common | Common Stock | 2024-04-01 | F | D | 2,653 | $79.56 | 47,273.46 | D | — | — | |
| 4 | Derivative | Stock Option | 2024-04-01 | A | A | 62,695 | $79.56 | 62,695 | D | $79.56 · 2025-04-01 to 2034-04-01 | 62,695 Common Stock |